Screener
Eligibility screening
Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStudy detailsClinicalTrials.gov
4 US sites in FL, MD, NY
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.